- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07537140
Microgreens on Sleep (GREENSLEEP)
April 12, 2026 updated by: DAMLA AYKORA, Çanakkale Onsekiz Mart University
Microgreen Consumption and Effects on Sleep Architecture
This study aims to investigate the effects of Microgreen use on sleep architecture in athletes.
Sleep architecture refers to the structural organization of sleep, including the distribution of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep stages, sleep onset latency, total sleep time, and sleep efficiency.
In athletic populations, optimal sleep is essential for recovery, hormonal regulation, cognitive performance, and physical adaptation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Çanakkale
-
Çanakkale, Çanakkale, Turkey (Türkiye), 17100
- Canakkale Onsekiz Mart University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- active athlete
Exclusion Criteria:
- with no cardiovascular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: control
only cabbage received
|
cabbage was orally given to control
|
|
Experimental: microgreen
microgreen coctail received
|
microgreen group received orally microgreen coctail
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DOMS
Time Frame: From the end of treatment at 3 weeks
|
Fit bitcharge measurements and BORG scale
|
From the end of treatment at 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- M Bhaswant
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 10, 2025
Primary Completion (Actual)
February 14, 2026
Study Completion (Actual)
March 4, 2026
Study Registration Dates
First Submitted
March 5, 2026
First Submitted That Met QC Criteria
April 12, 2026
First Posted (Actual)
April 17, 2026
Study Record Updates
Last Update Posted (Actual)
April 17, 2026
Last Update Submitted That Met QC Criteria
April 12, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ÇOMU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Architecture
-
Charite University, Berlin, GermanyWithdrawnSleep ArchitectureGermany
-
Swansea UniversityCompletedCognitive Function | Mood | Glucose Metabolism | Sleep ArchitectureUnited Kingdom
-
Ruhr University of BochumCompletedSleep Architecture Under Opioid MedicationGermany
-
University Hospital, BordeauxCompletedCognitive Impairment | Sleep Disorders | Sleep ArchitectureFrance
-
Karadeniz Technical UniversityThe Scientific and Technological Research Council of TurkeyRecruiting
-
Belun Technology Company LimitedStanford UniversityCompletedSleep-Disordered Breathing | Sleep ArchitectureUnited States
-
Charles University, Czech RepublicNot yet recruitingUltrasonic Diagnosis | Muscle ArchitectureCzechia
-
Medipol UniversityCompletedMuscle ArchitectureTurkey
-
Belun Technology Company LimitedUniversity Hospitals Cleveland Medical CenterCompletedSleep-Disordered Breathing | Sleep ArchitectureUnited States
Clinical Trials on cabbage for control
-
Inonu UniversityEnrolling by invitation
-
Colorado State UniversityCompleted
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming Chiao Tung UniversityNot yet recruiting
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
-
University of HartfordCompletedCerebral PalsyUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...UnknownAnkle Fractures | Proximal Humeral Fracture | Wrist FractureTurkey
-
CogCubed, CorpCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Istituto per la Ricerca e l'Innovazione BiomedicaCatholic University of the Sacred Heart; Madre Teresa s.r.l; Medilink s.r.l.; SB...RecruitingAnorexia Nervosa | Bulimia Nervosa | Eating DisordersItaly
-
University of NebraskaWithdrawn